Back to top
more

If you wish to go to ZacksFunds.com, click OK. If you do not, click Cancel.

Janus Global Life Sciences D Shs: (MF: JNGLX)

(MF) As of Feb 9, 2016 06:05 PM ET

 Add to portfolio

$42.30 USD

+0.25 (0.60%)

Is JNGLX a
Buy, Hold or Sell?

See its Zacks Rank in our free fund analysis report.

Get Free Report for JNGLX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Latest Performance as of Dec 31, 2015

Total Return %* Percentile Rank Objective
YTD 8.31 38
3 months 4.83 82
6 months -8.37 65
1 Year 8.31 38
3 Year 31.58 15
5 Year 24.98 20
10 Year 13.55 27

* Annual for three years and beyond.

Zacks Premium Research for JNGLX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank [?]
MF Research Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

%Unrealized Gain YTD 11.39
% Yield 0.27
% SEC Yield NA
Net Assets (Mil $) 12/31/2015 1,601.16
%Turnover 12/31/2015 47.00

Risk

3 Year 5 Year 10 Year
Beta 0.86 0.87 0.78
Alpha 17.52 13.41 7.36
R Squared 0.35 0.49 0.57
Std. Dev. 15.46 14.41 15.66
Sharpe 2.14 1.82 1.00

Sector / Country Weightings

As of 12/31/2015 % of Portfolio
Health 64.17
Other 13.60
Services 8.13
Finance 6.45
Industrial Cyclical 3.25
Technology 1.72
Retail Trade 1.44
Non-Durable 1.24

Portfolio Holdings

Top Equity Holdings
(As of 9/30/2015)
% of Portfolio Value (Mil$)
AMGEN INC 3.47 160.09
ABBVIE INC 2.73 125.77
SANOFI 2.67 123.40
VALEANT PHARMACEUTICALS 2.54 117.07
JOHNSON & JOHNSON 2.47 113.96
CELGENE CORP 2.44 112.74
AETNA INC 2.40 110.61
ALLERGAN PLC 2.33 107.72
BIOGEN INC 2.33 107.40

Stock Holding % of Net Assets

As Of 9/30/2015
Total Issues 91
Avg. P/E 27.19
Avg. P/Book 5.64
Avg. EPS Growth 12.69
Avg. Market Value (Mil $) 54,255

Allocation

% of Portfolio
Large Growth 9.97
Large Value 0.00
Small Growth 36.56
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 27.98
Foreign Bond 0.00
High Yield Bond 0.00